Sarcoma  >>  Selzentry (maraviroc)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Selzentry (maraviroc) / ViiV Healthcare
NCT01276236: Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Completed
2
13
US
Maraviroc, Selzentry(Celsentri outside US)
University of California, San Francisco, Pfizer, ViiV Healthcare
Kaposi's Sarcoma
01/15
04/15

Download Options